Figure 4From: HSV-tk/GCV gene therapy mediated by EBV-LMP1 for EBV-associated cancerpVLTR-tk/GCV restrain cell survival in LMP1 positive cells. Cells were transfected with pVLTR-tk and treated with GCV. Cell survival was measured by a Clonogenic assay.Back to article page